Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FMRP, FCFRP
Assunto: FARMACOLOGIA CLÍNICA
ABNT
PAPINI, Olga et al. Quantitative assay of lorazepam and its metabolite glucuronide by reverse-phase liquid chromatography-tandem mass spectrometry in human plasma and urine samples. Journal of Pharmaceutical and Biomedical Analysis, v. 40, p. 389-396, 2006Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2005.07.033. Acesso em: 08 out. 2024.APA
Papini, O., Bertucci, C., Cunha, S. P. da, Santos, N. A. G. dos, & Lanchote, V. L. (2006). Quantitative assay of lorazepam and its metabolite glucuronide by reverse-phase liquid chromatography-tandem mass spectrometry in human plasma and urine samples. Journal of Pharmaceutical and Biomedical Analysis, 40, 389-396. doi:10.1016/j.jpba.2005.07.033NLM
Papini O, Bertucci C, Cunha SP da, Santos NAG dos, Lanchote VL. Quantitative assay of lorazepam and its metabolite glucuronide by reverse-phase liquid chromatography-tandem mass spectrometry in human plasma and urine samples [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2006 ; 40 389-396.[citado 2024 out. 08 ] Available from: https://doi.org/10.1016/j.jpba.2005.07.033Vancouver
Papini O, Bertucci C, Cunha SP da, Santos NAG dos, Lanchote VL. Quantitative assay of lorazepam and its metabolite glucuronide by reverse-phase liquid chromatography-tandem mass spectrometry in human plasma and urine samples [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2006 ; 40 389-396.[citado 2024 out. 08 ] Available from: https://doi.org/10.1016/j.jpba.2005.07.033